TNYA
TNYA
NASDAQ · Biotechnology

Tenaya Therapeutics Inc

$0.67
-0.04 (-5.11%)
As of Mar 29, 10:36 PM ET ·
Financial Highlights (FY 2025)
Revenue
59.14M
Net Income
4.93M
Gross Margin
31.9%
Profit Margin
8.3%
Rev Growth
+23.4%
D/E Ratio
0.46
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 31.9% 31.9% 31.9%
Operating Margin 8.0% 8.0% 8.4%
Profit Margin 8.3% 8.4% 8.2%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 59.14M 52.95M 62.98M
Gross Profit 18.84M 16.87M 20.07M
Operating Income 4.73M 4.25M 5.31M
Net Income 4.93M 4.47M 5.16M
Gross Margin 31.9% 31.9% 31.9%
Operating Margin 8.0% 8.0% 8.4%
Profit Margin 8.3% 8.4% 8.2%
Rev Growth +23.4% +5.7% +6.5%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 55.11M 53.41M 65.28M
Total Equity 120.13M 125.92M 131.81M
D/E Ratio 0.46 0.42 0.50
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 5.59M 4.86M 6.72M
Free Cash Flow 3.58M 3.18M 3.67M